Join
Live feed
·
PRReleasevia Quantisnow
OptiNose Inc. logo

Paratek Pharmaceuticals Completes Acquisition of Optinose, Creating an Expanded Portfolio of Specialty Therapies

ByQuantisnow·Wall Street's wire, on your screen.
OPTN· OptiNose Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OPTN (OptiNose Inc.) and more on Quantisnow.